Methoxyacetylfentanyl

Methoxyacetylfentanyl

File:Methoxyacetylfentanyl Structure.svg
File:Methoxyacetylfentanyl 3D BS.png
Legal status
Legal status	BR: Class F1 (Prohibited narcotics) CA: Schedule I DE: Anlage II (Authorized trade only, not prescriptible) UK: Class A US: Schedule I
Identifiers
IUPAC name 2-Methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide
CAS Number	101345-67-9
PubChem CID	968688
ChemSpider	838859
UNII	U7IAB3Z3V4
KEGG	C22794 checkY
ChEMBL	ChEMBL1740467
E number	{{#property:P628}}
CompTox Dashboard (EPA)	{{#property:P3117}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C22H28N2O2
Molar mass	352.478 g·mol−1
3D model (JSmol)	Interactive image
SMILES c3ccccc3N(C(=O)COC)C1CCN(CC1)CCc2ccccc2
InChI InChI=1S/C22H28N2O2/c1-26-18-22(25)24(20-10-6-3-7-11-20)21-13-16-23(17-14-21)15-12-19-8-4-2-5-9-19/h2-11,21H,12-18H2,1H3 Key:SADNVKRDSWWFTK-UHFFFAOYSA-N

Methoxyacetylfentanyl, commonly known as MAF is an opioid analgesic that is an analog of fentanyl and has been sold online as a designer drug.

Side effects

Side effects of fentanyl analogs are similar to those of fentanyl itself, which include itching, nausea and potentially serious respiratory depression, which can be life-threatening. Fentanyl analogs have killed hundreds of people throughout Europe and the former Soviet republics since the most recent resurgence in use began in Estonia in the early 2000s, and novel derivatives continue to appear. A new wave of fentanyl analogues and associated deaths began in around 2014 in the US, and have continued to grow in prevalence; especially since 2016 these drugs have been responsible for hundreds of overdose deaths every week.

Legal status

Methoxyacetylfentanyl was placed into Schedule I in the US in October 2017, in order to avoid an imminent hazard to public safety.

See also

• α-Methylfentanyl
• Acetylfentanyl
• Butyrfentanyl
• Fentanyl carbamate
• Furanylfentanyl
• List of fentanyl analogues